Menu

Markets

Research

News

Learn
Paper trading
AI Chat
WatchlistsPortfoliosAlerts
Sign in

FBIOP

Fortress Biotech, Inc.

Healthcare · USD

Set alert

Price alert · FBIOP

All alert types
15.10 USD -0.49 -3.14%
As of Oct 30, 2026 Extended hours 15.32 +1.46%
Bid
15.05 × 2
Ask
15.10 × 3
15.05 Day range 15.76
6.53 52-week range 21.08
YTD
+59.11%
1 year
+120.12%
Open
15.39
Prev close
15.59
Mkt cap
35.16M
Vol
24.34K
Avg vol
12.22K
EPS
-0.863
P/E
0.00
Div yield
45.96%
More statistics
Low
15.05
High
15.76
Forward P/E
0.00
Beta
1.75
Short ratio
0.00
Inst. own
0.00%
Dividend
2.34
Ex-div date
Jun 13, 2024
50-d avg
5.83
200-d avg
10.33
1y target
0.00

5D chart

Chart tools
Interval
1m5m15m30m
FBIOP five-day price chart15.115.415.816.116.5Oct 26Oct 27Oct 28Oct 29Oct 30

Financial health

Altman Z-Score

-1.15 Distress zone

Bankruptcy-risk model: below 1.81 distress, above 2.99 safe.

Piotroski F-Score

5 / 9 Average

Nine pass/fail tests of profitability, leverage and efficiency.

FMP rating

C-1 / 5 overall

  • DCF 1
  • Return on Equity 1
  • Return on Assets 1
  • Debt / Equity 1
  • P/E 4
  • P/B 1

Valuation

P/E -54.3×
FY 2016: -2.0×FY 2017: -2.5×FY 2018: -0.4×FY 2019: -3.5×FY 2020: -4.9×FY 2021: -3.2×FY 2022: -0.7×FY 2023: -0.4×FY 2024: -0.8×FY 2025: -54.3×
FY 2016 5y median -0.8× FY 2025
P/S 1.6×
FY 2016: 6.5×FY 2017: 0.9×FY 2018: 1.4×FY 2019: 3.8×FY 2020: 5.0×FY 2021: 3.0×FY 2022: 0.8×FY 2023: 0.3×FY 2024: 0.7×FY 2025: 1.6×
FY 2016 5y median 0.8× FY 2025
P/B 2.0×
FY 2016: 2.8×FY 2017: 3.2×FY 2018: 20.2×FY 2019: 5.4×FY 2020: 2.3×FY 2021: 1.9×FY 2022: 1.4×FY 2023: 1.1×FY 2024: 1.9×FY 2025: 2.0×
FY 2016 5y median 1.9× FY 2025
P/FCF -1.6×
FY 2016: -1.9×FY 2017: -1.8×FY 2018: -0.3×FY 2019: -1.3×FY 2020: -2.5×FY 2021: -1.5×FY 2022: -0.3×FY 2023: -0.2×FY 2024: -0.4×FY 2025: -1.6×
FY 2016 5y median -0.4× FY 2025
EV/EBITDA -4.8×
FY 2016: -0.7×FY 2017: -1.3×FY 2018: -0.4×FY 2019: -1.3×FY 2020: -1.0×FY 2021: 0.2×FY 2022: -0.0×FY 2023: -0.2×FY 2024: -0.6×FY 2025: -4.8×
FY 2016 5y median -0.2× FY 2025
EV/Sales 1.5×
FY 2016: 2.9×FY 2017: 0.6×FY 2018: 1.9×FY 2019: 3.2×FY 2020: 1.8×FY 2021: -0.4×FY 2022: 0.1×FY 2023: 0.3×FY 2024: 1.1×FY 2025: 1.5×
FY 2016 5y median 0.3× FY 2025
FCF Yield -64.4%
FY 2016: -52.2%FY 2017: -54.7%FY 2018: -289.5%FY 2019: -74.2%FY 2020: -39.8%FY 2021: -65.1%FY 2022: -311.1%FY 2023: -558.4%FY 2024: -225.6%FY 2025: -64.4%
FY 2016 5y median -225.6% FY 2025

Profitability

Gross Margin 66.9%
FY 2016: 31.1%FY 2017: 14.1%FY 2018: 77.2%FY 2019: 71.2%FY 2020: 68.0%FY 2021: 53.4%FY 2022: 59.4%FY 2023: 72.9%FY 2024: 63.8%FY 2025: 66.9%
FY 2016 5y median 63.8% FY 2025
Operating Margin -111.0%
FY 2016: -398.7%FY 2017: -47.9%FY 2018: -446.4%FY 2019: -302.5%FY 2020: -206.7%FY 2021: -274.1%FY 2022: -268.8%FY 2023: -168.4%FY 2024: -191.4%FY 2025: -111.0%
FY 2016 5y median -191.4% FY 2025
Net Margin 10.8%
FY 2016: -334.3%FY 2017: -35.7%FY 2018: -313.0%FY 2019: -109.1%FY 2020: -102.0%FY 2021: -94.1%FY 2022: -114.3%FY 2023: -71.7%FY 2024: -79.8%FY 2025: 10.8%
FY 2016 5y median -79.8% FY 2025
ROE 13.7%
FY 2016: -143.1%FY 2017: -127.2%FY 2018: -4543.6%FY 2019: -152.4%FY 2020: -46.4%FY 2021: -59.5%FY 2022: -207.5%FY 2023: -269.0%FY 2024: -202.3%FY 2025: 13.7%
FY 2016 5y median -202.3% FY 2025
ROIC -50.0%
FY 2016: -56.6%FY 2017: -47.8%FY 2018: -114.5%FY 2019: -58.4%FY 2020: -32.7%FY 2021: -62.2%FY 2022: -113.6%FY 2023: -161.5%FY 2024: -145.1%FY 2025: -50.0%
FY 2016 5y median -113.6% FY 2025
ROA 3.7%
FY 2016: -32.3%FY 2017: -27.2%FY 2018: -59.7%FY 2019: -17.6%FY 2020: -14.0%FY 2021: -16.3%FY 2022: -29.4%FY 2023: -36.2%FY 2024: -31.9%FY 2025: 3.7%
FY 2016 5y median -29.4% FY 2025

Growth (YoY)

Revenue 9.7%
FY 2016: 1809.6%FY 2017: 1038.3%FY 2018: -85.7%FY 2019: 36.3%FY 2020: 24.5%FY 2021: 50.9%FY 2022: 10.1%FY 2023: 11.6%FY 2024: -31.8%FY 2025: 9.7%
FY 2016 FY 2025
Operating Income 36.4%
FY 2016: -30.0%FY 2017: -36.7%FY 2018: -33.6%FY 2019: 7.6%FY 2020: 14.9%FY 2021: -100.0%FY 2022: -8.0%FY 2023: 30.1%FY 2024: 22.5%FY 2025: 36.4%
FY 2016 FY 2025
EPS (diluted) 98.0%
FY 2016: -11.4%FY 2017: -16.4%FY 2018: -20.6%FY 2019: 62.3%FY 2020: 11.0%FY 2021: -21.5%FY 2022: -22.8%FY 2023: 41.8%FY 2024: 68.2%FY 2025: 98.0%
FY 2016 FY 2025
Free Cash Flow 30.9%
FY 2016: -74.0%FY 2017: -61.4%FY 2018: -19.1%FY 2019: 3.6%FY 2020: 12.9%FY 2021: -46.3%FY 2022: -37.3%FY 2023: 25.3%FY 2024: 30.2%FY 2025: 30.9%
FY 2016 FY 2025

Financial Health

Current Ratio 2.5×
FY 2016: 1.9×FY 2017: 2.6×FY 2018: 2.0×FY 2019: 3.4×FY 2020: 5.1×FY 2021: 3.4×FY 2022: 1.8×FY 2023: 1.4×FY 2024: 1.3×FY 2025: 2.5×
FY 2016 5y median 1.8× FY 2025
Quick Ratio 2.3×
FY 2016: 1.9×FY 2017: 2.6×FY 2018: 2.0×FY 2019: 3.4×FY 2020: 5.1×FY 2021: 3.3×FY 2022: 1.7×FY 2023: 1.3×FY 2024: 1.1×FY 2025: 2.3×
FY 2016 5y median 1.7× FY 2025
Debt / Equity 1.5×
FY 2016: 0.7×FY 2017: 1.2×FY 2018: 42.9×FY 2019: 4.4×FY 2020: 0.9×FY 2021: 0.7×FY 2022: 3.1×FY 2023: 3.8×FY 2024: 3.3×FY 2025: 1.5×
FY 2016 5y median 3.1× FY 2025
Net Debt / EBITDA 0.3×
FY 2016: 0.9×FY 2017: 0.6×FY 2018: -0.1×FY 2019: 0.2×FY 2020: 1.6×FY 2021: 1.6×FY 2022: 0.3×FY 2023: -0.0×FY 2024: -0.2×FY 2025: 0.3×
FY 2016 5y median 0.3× FY 2025
Interest Coverage -8.1×
FY 2016: -17.8×FY 2017: -11.7×FY 2018: -11.6×FY 2019: -9.4×FY 2020: -6.2×FY 2021: -12.3×FY 2022: -14.9×FY 2023: -11.4×FY 2024: -11.1×FY 2025: -8.1×
FY 2016 5y median -11.4× FY 2025

Dividends

Dividend Yield 0.7%
FY 2016: 0.0%FY 2017: 0.2%FY 2018: 6.3%FY 2019: 1.8%FY 2020: 3.0%FY 2021: 4.3%FY 2022: 15.0%FY 2023: 35.9%FY 2024: 11.2%FY 2025: 0.7%
FY 2016 5y median 11.2% FY 2025
Payout Ratio 9.7%
FY 2016: 0.0%FY 2017: -0.4%FY 2018: -2.8%FY 2019: -6.4%FY 2020: -14.5%FY 2021: -13.6%FY 2022: -10.1%FY 2023: -14.5%FY 2024: -10.2%FY 2025: 9.7%
FY 2016 5y median -10.2% FY 2025

Annual · latest fiscal year ends 2025-12-31